by: TigerPosted on: June 29, 2010June 29, 2010 FDA accepts BioMimetics PMA application for its human platelet-derived growth factor (rhPDGF-BB) for use in foot and ankle fusions Email LinkedIn Facebook Twitter BioMimetic Therapeutics Receives Filing Letter from FDA for Augment™ Bone Graft PMA (Press Release)
